Juvenile Rheumatic Fever - Causes, Treatment & When to See a Doctor

What is Juvenile Rheumatic Fever?

Juvenile rheumatic fever (JRF) is an inflammatory disease that occurs in children and adolescents after an infection with group A Streptococcus (GAS) bacteria, most commonly a strep throat or scarlet fever. The condition is an autoimmune reaction: the body’s immune system, while trying to fight the bacteria, mistakenly attacks its own tissues, especially the heart, joints, skin, and central nervous system. When this response involves the heart, it is called rheumatic heart disease, which can lead to permanent valve damage if left untreated.

JRF most often affects children ages 5‑15, but it can appear in younger or older teenagers. The disease follows a classic pattern of three stages: (1) a preceding streptococcal infection, (2) a latency period of 1‑3 weeks, and (3) the acute inflammatory phase with characteristic signs and symptoms.

Sources: Mayo Clinic, CDC, WHO

Common Causes

Juvenile rheumatic fever is not caused by a single factor but by a cascade of events that start with a streptococcal infection. The following conditions or factors are most often linked to the development of JRF:

• Group A Streptococcal pharyngitis (strep throat) – the primary trigger.
• Scarlet fever – a streptococcal infection that presents with a rash.
• Unresolved or poorly treated streptococcal infections – lack of appropriate antibiotics or delayed treatment.
• Recurrent streptococcal infections – multiple episodes increase immune sensitization.
• Family history of rheumatic fever – genetic predisposition to an exaggerated immune response.
• Crowded living conditions – facilitate spread of GAS bacteria.
• Poor socioeconomic status – associated with limited access to healthcare and delayed treatment.
• Immune system dysregulation – certain HLA types (e.g., HLA‑DR7) have been linked to higher risk.
• Co‑existing viral infections – may modulate immune response and increase susceptibility.
• Seasonal peaks – higher incidence in winter and early spring when streptococcal infections are common.

Associated Symptoms

The clinical picture of juvenile rheumatic fever is variable, but most children develop a combination of the following features, often summarized by the “Jones Criteria” (revised 2015):

• Carditis – chest pain, shortness of breath, tachycardia, new heart murmur, or pericardial friction rub.
• Polyarthritis – migratory, painful swelling of large joints (knees, ankles, elbows, wrists) that typically lasts a few days per joint.
• Sydenham chorea – involuntary, rapid, jerky movements of the face, hands, and feet; emotional lability and muscle weakness may accompany it.
• Erythema marginatum – a pink, non‑itchy rash with a serpiginous border that appears on the trunk and limbs.
• Subcutaneous nodules – painless, firm nodules over bony prominences (e.g., elbows, knees, scalp).
• Fever – usually low‑grade (38‑39°C) but can be higher during acute inflammation.
• Fatigue and malaise – general feeling of being unwell.
• Joint stiffness – especially in the morning.

Not all symptoms need to be present for a diagnosis; a combination of major (e.g., carditis, polyarthritis) and minor criteria (e.g., fever, elevated acute‑phase reactants) is used alongside evidence of a recent streptococcal infection.

When to See a Doctor

Because JRF can cause lasting heart damage, early medical evaluation is crucial. Parents and caregivers should seek care promptly if a child shows any of the following:

• Fever that persists more than 48 hours after a known strep throat or scarlet fever.
• Sudden, severe joint pain that moves from one joint to another.
• Chest pain, shortness of breath, or a new heart murmur heard by a caregiver.
• Unexplained rash that spreads quickly or has a “ring‑like” pattern.
• Involuntary movements or abnormal facial expressions (possible chorea).
• Swelling or tenderness under the skin over bony areas (subcutaneous nodules).
• Any combination of fever, joint pain, and rash following a recent sore throat.

If any of these signs appear, especially in a child who recently had a sore throat, contact a pediatrician or go to an urgent‑care clinic without delay.

Diagnosis

Diagnosing juvenile rheumatic fever involves a combination of clinical assessment, laboratory testing, and sometimes imaging:

1. Clinical Evaluation

• Detailed history of recent upper‑respiratory infection (e.g., sore throat, scarlet fever).
• Physical exam focusing on heart sounds, joint inflammation, skin lesions, and neurologic signs.

2. Evidence of Recent Streptococcal Infection

• Rapid antigen detection test (RADT) or throat culture – if performed during the acute throat illness.
• Antistreptolysin O (ASO) titer – elevated 1‑3 weeks after infection.
• Anti‑DNAse B antibodies – useful when ASO is normal but suspicion remains.

3. Laboratory Markers of Inflammation

• Erythrocyte sedimentation rate (ESR) – usually markedly increased.
• C‑reactive protein (CRP) – rises in parallel with disease activity.
• Complete blood count (CBC) – often shows mild leukocytosis.

4. Cardiac Assessment

• Echocardiography – critical for detecting valve inflammation (regurgitation) or myocardial involvement even when a murmur is not audible.
• Electrocardiogram (ECG) – may reveal conduction abnormalities or arrhythmias.

5. Application of Jones Criteria

The 2015 revision of the Jones Criteria distinguishes between low‑risk and high‑risk populations. In most high‑income countries, the criteria for diagnosing JRF in a low‑risk child are:

• ≥2 major criteria, or 1 major + ≥2 minor criteria, plus evidence of a recent streptococcal infection.

In high‑risk populations (e.g., certain low‑resource regions), a single major criterion is sufficient when paired with laboratory evidence.

Sources: American Heart Association, CDC, NICE guidelines

Treatment Options

Treatment aims to eradicate any residual streptococcal bacteria, control inflammation, and prevent recurrence.

1. Antibiotic Therapy

• Penicillin V orally for 10 days (or a single intramuscular dose of benzathine penicillin G) – first‑line for eradication of GAS.
• If allergic to penicillin, erythromycin or a macrolide (e.g., azithromycin) for 10 days.
• After the acute episode, **secondary prophylaxis** with monthly benzathine penicillin G (or daily oral penicillin) is continued for 5–10 years, or until echocardiography shows no residual heart disease.

2. Anti‑Inflammatory Medications

• Aspirin (30‑50 mg/kg/day divided every 4–6 hours) for 2–4 weeks to reduce joint pain and fever.
• For severe carditis or when aspirin is contraindicated, corticosteroids** (e.g., prednisone 1–2 mg/kg/day) may be prescribed.